Literature DB >> 10740231

Age-dependent changes in adenosine A1 receptor and uptake site binding in the mouse brain: an autoradiographic study.

A Ekonomou1, O Pagonopoulou, F Angelatou.   

Abstract

Ageing is a multifactorial, inevitable event of life span, which affects neurotransmission in the CNS. Since adenosine is a major neuromodulator of the synaptic activity, it was of interest to investigate the possible modification of the adenosinergic system in the brain during ageing. Using "in vitro" quantitative autoradiography and the radioactive ligands [(3)H]Cyclohexyladenosine and [(3)H]Nitrobenzylthioinosine, we have studied the distribution of A1 adenosine receptors and adenosine uptake sites in the aged mice (26 months) compared to the young ones (3 months). Our results showed a widespread reduction in A1 receptor binding in the aged animals, which was brain area-specific, occurring in areas where adenosine plays a significant neuromodulatory role such as the hippocampus, cortex, basal ganglia, and thalamus. Interestingly, the significant reduction in NBI-sensitive adenosine uptake sites was restricted to few areas of the aged brain, mainly in thalamic nuclei. Since the alterations in the density of A1 receptors and adenosine uptake sites showed no regional correlation and since no significant changes in either neuronal or glial cell number are observed, at least in hippocampus and cortex in this mouse strain during ageing, our findings could be explained by a selective age-dependent reduction of these adenosinergic components rather than by a general neuronal cell degeneration. As adenosine depresses electrical activity in hippocampus, a downregulation of adenosinergic function could probably be related to enhanced excitability seen in hippocampal neurons of the CA1 subregion and dentate gyrus of aged animals. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10740231     DOI: 10.1002/(SICI)1097-4547(20000415)60:2<257::AID-JNR15>3.0.CO;2-U

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Functional coupling between adenosine A1 receptors and G-proteins in rat and postmortem human brain membranes determined with conventional guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding or [35S]GTPγS/immunoprecipitation assay.

Authors:  Yuji Odagaki; Masakazu Kinoshita; Toshio Ota; J Javier Meana; Luis F Callado; Isao Matsuoka; Jesús A García-Sevilla
Journal:  Purinergic Signal       Date:  2018-02-28       Impact factor: 3.765

Review 2.  Sleep and Human Aging.

Authors:  Bryce A Mander; Joseph R Winer; Matthew P Walker
Journal:  Neuron       Date:  2017-04-05       Impact factor: 17.173

3.  Age-dependent changes in adenosine A1 receptor distribution and density within the nucleus tractus solitarii of normotensive and hypertensive rats.

Authors:  D C Carrettiero; D R Fior-Chadi
Journal:  J Neural Transm (Vienna)       Date:  2008-05-08       Impact factor: 3.575

4.  Reduced impact of alcohol use on next-day tiredness in older relative to younger adults: A role for sleep duration.

Authors:  David M Lydon-Staley; Nilam Ram; Annette Brose; Florian Schmiedek
Journal:  Psychol Aging       Date:  2017-10-12

5.  Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade.

Authors:  Rodrigo A Cunha
Journal:  Purinergic Signal       Date:  2005-03-17       Impact factor: 3.765

6.  ATP signalling in epilepsy.

Authors:  Ashwin Kumaria; Christos M Tolias; Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2008-06-21       Impact factor: 3.765

7.  Electroacupuncture Pretreatment Alleviates Cerebral Ischemia-Reperfusion Injury by Increasing GSK-3β Phosphorylation Level via Adenosine A1 Receptor.

Authors:  Wujun Geng; Libin Cai; Kunyuan Han; Ding Li; Yunchang Mo; Qinxue Dai; Hongli Tang; Minyuan Zhang; Percy David Papa Akuetteh; Meita Felicia Balelang; Junlu Wang
Journal:  Biomed Res Int       Date:  2020-02-20       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.